Expert Discusses Promise of Immunotherapy in TNBC

Expert Discusses Promise of Immunotherapy in TNBCAngelica Welch @awelchhhh

Published Online: Friday, Mar 17, 2017

The combination of immunotherapy and chemotherapy is showing promising response rates in certain patients with triple-negative breast cancer (TNBC), said ESO Umberto Veronesi Memorial Award Winner Giuseppe Curigliano, MD, PhD, who addressed genetic determinants of breast cancer immunogenicity in his award lecture at the 15th St. Gallen International Breast Cancer Conference. 

– See more at: http://www.onclive.com/conference-coverage/st-gallen-2017/expert-discusses-promise-of-immunotherapy-in-tnbc#sthash.vMO84Khg.dpuf

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s